Preoperative Evaluation and Management of Myelofibrosis Patients Undergoing Splenectomy
Critical Preoperative Requirements
- The American Society of Clinical Oncology recommends cytoreductive therapy before surgery to prevent postoperative extreme thrombocytosis, which significantly increases thrombotic complications 1, 2
- Maintain platelet count strictly below 400 × 10⁹/L using hydroxyurea or other cytoreductive agents 1, 2
- Severe thrombocytopenia (<100 × 10⁹/L) is a marker of impending leukemic transformation and significantly worsens postoperative survival—reconsider surgical candidacy in these patients 1
Infection Prophylaxis Requirements
- The Centers for Disease Control and Prevention recommends all patients receive immunization against encapsulated bacteria at least 14 days before elective splenectomy 3, 4, 5
- Required vaccines include: polyvalent pneumococcal (23-valent), meningococcal C conjugate, and Haemophilus influenzae type B 3, 5
- Arrange lifelong prophylactic antibiotics (phenoxymethylpenicillin or erythromycin if penicillin-allergic) starting immediately postoperatively 3
Thrombotic Risk Assessment
- The American College of Chest Physicians recommends initiate prophylactic anticoagulation with low molecular weight heparin (LMWH) as a preoperative measure 1, 2, 5
- Extended prophylaxis with LMWH should continue postoperatively given the high-risk nature of splenectomy 6
Absolute Contraindications to Surgery
- Poor performance status—patient must have adequate functional capacity to tolerate major surgery 1
- Clinical or laboratory evidence of disseminated intravascular coagulation (DIC)—this is an absolute contraindication 1
- Active infection of any kind 5
Risk Stratification and Informed Consent
- Perioperative mortality ranges from 5-10% in myelofibrosis patients 1, 2
- Postsplenectomy complications occur in approximately 50% of patients 1, 2
Surgical Team Requirements
- An experienced surgical team is mandatory given the complexity and high complication rates 1
- Multidisciplinary coordination with hematology, anesthesiology, and perioperative medicine teams is essential 6, 5
Postoperative Monitoring Plan
- Aggressive surveillance for arterial or venous thrombosis symptoms 6
- Monitor for extreme thrombocytosis and initiate immediate cytoreduction if platelet count rises rapidly 1
- Implement mechanical prophylaxis (sequential compression devices) immediately and continue throughout hospitalization 5
- Lifelong risk of overwhelming post-splenectomy infection (OPSI) with mortality rates approaching 50% for pneumococcal sepsis 5
- Educate patient that any fever >38°C (101°F) requires immediate emergency department evaluation 5
- Provide home supply of antibiotics for immediate use if fever develops 3, 5
- Reimmunization recommended every 5-10 years 3